Charting a New Course | Episode 18
In this week’s podcast, Murray’s co-host is Eliane Boucher, Happify Health’s Senior Director of Research Strategy to share some news that will give hope to patients dealing with psoriasis. They’re joined by Theo Ahadome, SVP of commercialization at Happify, and Mohanad Fors, the Head of Global Commercial Digital Innovation at the global biopharmaceutical company, Almirall.
The discussion goes in depth about an innovative new whole-patient approach to psoriasis, and without spoiling too much, we’re excited to announce that Happify and Almirall are teaming up to help psoriasis patients, with the rollout of a digital solution called CLARO. Almirall has made impressive strides in the fight against psoriasis. And now, Happify is joining forces with them to offer digital programs to patients in order to fuel more well-rounded solutions that support mental health issues associated with the disease like anxiety and depression. Happify Health’s evidence-based and clinically validated platforms deliver mental health solutions to patients who deal with chronic diseases like psoriasis.
Tune in to learn more about CLARO and the benefits it will deliver.
